COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,802 Articles (22,527 medRxiv, 8,275 bioRxiv)

Most recent first Previous |  Page 1753: Articles 17521-17530  | Next

E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies
Wang, W. B., Liang, Y., Jin, Y. Q., Zhang, J., Su, J. G., Li, Q. M.
10.1101/2021.02.17.431566 — Posted: 2021-02-17
Are there significant correlations between climate factors and the spread of COVID-19 for less densely populated and less polluted regions?
de Paula Correa, M., Yamamoto, A. L. C., Silva, L. F., Bastos, I., Matias, T., Pereira, R., Fagundes, F., Ribeiro, A., Moraes, J., Silva, F.
10.1101/2021.02.11.21251129 — Posted: 2021-02-17
Should We Delay the Second COVID-19 Vaccine Dose?
Harizi, I., Berkane, S., Tayebi, A.
10.1101/2021.02.13.21251652 — Posted: 2021-02-17
COVID-19 European Regional Tracker
Naqvi, A.
10.1101/2021.02.15.21251788 — Posted: 2021-02-17
Epidemiological dynamics of the incidence of COVID-19 in children and the relationship with the opening of schools in Catalonia (Spain)
Perramon, A., Soriano-Arandes, A., Pino, D., Lazcano, U., Andres, C., Catala, M., Gatell, A., Carulla, M., Canadell, D., Ricos, G., Riera-Bosch, M. T., Burgaya, S., Salvado, O., Cantero, J., Vila, M., Poblet, M., Sanchez, A., Ristol, A. M., Serrano, P., Anton, A., Prats, C., Soler-Palacin, P.
10.1101/2021.02.15.21251781 — Posted: 2021-02-17
Seroprevalence of anti-SARS-CoV-2 IgG antibodies among truck drivers and assistants in Kenya
Kagucia, E. W., Gitonga, J. N., Kalu, C., Ochomo, E., Ochieng, B., Kuya, N., Karani, A., Nyagwange, J., Karia, B., Mugo, D., Karanja, H. K., Tuju, J., Mutiso, A., Maroko, H., Okubi, L., Maitha, E., Ajuck, H., Bogita, M., Mudindi, R., Mukabi, D., Moracha, W., Bulimu, D., Andanje, N., Shiraku, E., Okuku, R., Ogutu, M., Aman, R., Mwangangi, M., Amoth, P., Kasera, K., Ng'ang'a, W., Mariga, R., Munabi, T., Ramadhan, S. M., Mwikali, J., Nasike, R., Andera, C., Nechesa, R., Kiplagat, B. K., Omengo, J., Oteba, S., Mwangi, A., Mkanyi, D., Karisa, G., Migosi, J. K., Msili, P., Mwambire, S., Boniface, A. M., Nyaguara, A., Voller, S., Otiende, M., Bottomley, C., Agoti, C. N., Ochola-Oyier, L. I., Adetifa, I. M. O., Etyang, A. O., Gallagher, K. E., Uyoga, S., Barasa, E., Bejon, P., Tsofa, B., Agweyu, A., Warimwe, G. M., Scott, J. A. G.
10.1101/2021.02.12.21251294 — Posted: 2021-02-17
Overall burden and characteristics of COVID-19 in the United States during 2020
Pei, S., Yamana, T. K., Kandula, S., Galanti, M., Shaman, J.
10.1101/2021.02.15.21251777 — Posted: 2021-02-17
Protocol for Safe, Affordable, and Reproducible Isolation and Quantitation of SARS-CoV-2 RNA from Wastewater
Trujillo, M., Cheung, K., Gao, A., Hoxie, I., Kannoly, S., Kubota, N., San, K. M., Smith, D. S., Dennehy, J. J.
10.1101/2021.02.16.21251787 — Posted: 2021-02-17
The efficacy and safety of Favipiravir in treatment of COVID-19: A systematic review and meta-analysis of clinical trials
Hassanpour, S., Arab-Zozani, M., Amani, B., Heidarzad, F., Fathalipour, M., Martinez-de-Hoyo, R.
10.1101/2021.02.14.21251693 — Posted: 2021-02-17
Use of Convalescent Plasma Therapy among Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Single-Center Experience
Mesina, F. Z., Mangahas, C. G., Gatchalian, E. M., Ramos, M. S. A., Torres, R. P.
10.1101/2021.02.16.21251824 — Posted: 2021-02-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).